Anti-SLAMF7 antibody, elotuzumab, does not induce significant ADCC against chronic lymphocytic leukemia B-cells.
About the publication
Record:
ŠARIŠSKÝ, Marek - KĽOC, Dominik - DUBIKOVÁ, Bianca - CUPROVÁ, Michelle - TEJOVÁ, Martina - KURHAJEC, Slavomír - SÝKORA, Ján - GUMAN, Tomáš. Anti-SLAMF7 antibody, elotuzumab, does not induce significant ADCC against chronic lymphocytic leukemia B-cells. In: Czech-Slovak pharmacological days. 72nd Czech-Slovak pharmacological days abstract book : abstract book. 1. vyd. Košice : UPJŠ, 2025. 2025. ISBN 978-80-574-0420-0, s. 40.
Year:
2025
Category:
V2 - The scientific output of a publication activity as part of an edited book or collection
Output type:
ABP - abstract from the event
Authors:
ŠARIŠSKÝ Marek
0 %
0 %
DUBIKOVÁ Bianca
0 %
CUPROVÁ Michelle
0 %
TEJOVÁ Martina
0 %
SÝKORA Ján
0 %
GUMAN Tomáš
0 %
UVMP share:
0 %
Autori vydania:
MIROSSAY Ladislav, MIROŠŠAY Andrej, MOJŽIŠ Ján, DUKÁT Andrej, GAŽOVÁ Andrea
Edition:
72nd Czech-Slovak pharmacological days abstract book
abstract book
S. 40
Publisher:
UPJŠ
Issue number:
1. vyd.
Place of issue:
Košice
Country of issue:
Slovakia
ISBN:
978-80-574-0420-0
Research area:
neuvedená
Language:
english